FGF2 and central nervous system cancer: Interestingly, the induction of the expression of DACH1 decreased cell proliferation in a series of glioma cell lines, whereas loss of DACH1 increased the number of tumor-initiating cells through transcriptional activation of bFGF (Watanabe et al. 2011).